GET THE APP
Circulating Angiotensin Innovations | Open Access Journals
Journal of Health & Medical Informatics

Journal of Health & Medical Informatics

ISSN: 2157-7420

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Circulating Angiotensin Innovations

Angiotensin-converting enzyme 2 is a newly recognized ACE homolog within the renin-angiotensin system (RAS) that is produced and secreted by a variety of cell types. Although ACE2 may act on proportionate substrates, it exhibits high catalytic efficiency, specifically for the hydrolysis of angiotensin (Ang) II to the vasodilator and growth inhibitor heptapeptide. Innovations are new notion, device or process. Innovations are the engrossment of better solutions that meet new engrossment, inarticulated needs or existing market needs. It is proficient through more potent products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something coinage and novel, as a significant, new that “breaks into” the market or society. The renin-angiotensin system (RAS) is considered as a major endocrine regulator of cardiovascular homeostasis. The RAS acts in endocrine, paracrine, and autocrine manner in several organs and systems exercising various organ-specific actions with effects on the cardiovascular system.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 2700

Journal of Health & Medical Informatics received 2700 citations as per Google Scholar report

Citation image
Journal of Health & Medical Informatics peer review process verified at publons
Publon image

Indexed In

Related Links

 

Open Access Journals

arrow_upward arrow_upward